RecruitingNot ApplicableNCT06728826

Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

Pericardiotomy for Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery in China


Sponsor

Changhai Hospital

Enrollment

650 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

PRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Posterior pericardiotomy for people with atrial fibrillation (af), cardiac events, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPosterior pericardiotomy

The surgeon will perform a posterior pericardiotomy while the patient is on cardiopulmonary bypass. In detail, a 4-cm opening in the posterior pericardium will be made with a cautery between the left inferior pulmonary vein and the diaphragm. Then a soft channel drain will be placed through the opening in pericardium with the tip into the left pleural space.


Locations(1)

Changhai Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06728826


Related Trials